Dimensional Fund Advisors’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Dimensional Fund Advisors's PRME Position: Q3 2026 in Review
Dimensional Fund Advisors reduced its Prime Medicine (PRME) stake by 96% in Q3 2026, selling an estimated $968K and leaving 13,362 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.
Dimensional Fund Advisors first reported a position in PRME in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.12M in Q2 2026. 187 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Dimensional Fund Advisors held 13,362 shares of Prime Medicine worth $40.8K as of Q3 2026.
- Dimensional Fund Advisors sold 291,316 Prime Medicine shares in Q3 2026, an estimated $968K.
- Prime Medicine made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3201 holding.
- Dimensional Fund Advisors first reported a position in Prime Medicine in Q4 2025 and has held it in 4 quarters since.
- Dimensional Fund Advisors's Prime Medicine position peaked at $1.12M in Q2 2026.
- 187 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.